medmix AG (MEDX) — Capital Reinvestment Ratio
Latest as of December 2025:
0.50x
medmix AG (MEDX) has a Capital Reinvestment Ratio of 0.50x as of December 2025, meaning it reinvests 1% of its operating cash flow (CHF37.40 Million) in capital expenditures (CHF18.80 Million). See how much free cash does medmix AG generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.50x
Capex / Operating Cash Flow
Operating Cash Flow
CHF37.40 Million
CHF
Capital Expenditures
CHF18.80 Million
CHF
Data as of
Dec 2025
Most recent filing
medmix AG Capital Reinvestment Ratio (2018–2025)
This chart tracks medmix AG's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for medmix AG (2018–2025)
Year-by-year Capital Reinvestment Ratio for medmix AG from 2018 to 2025. For live market cap and broader valuation context, see medmix AG market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.51x | CHF67.80 Million | CHF34.50 Million | ▼ -9.1% |
| 2024 | 0.56x | CHF86.60 Million | CHF48.50 Million | ▼ -40.6% |
| 2023 | 0.94x | CHF56.10 Million | CHF52.90 Million | ▲ +16.3% |
| 2022 | 0.81x | CHF47.60 Million | CHF38.60 Million | ▲ +121.9% |
| 2021 | 0.37x | CHF87.30 Million | CHF31.90 Million | ▼ -57.1% |
| 2020 | 0.85x | CHF50.60 Million | CHF43.10 Million | ▲ +109.7% |
| 2019 | 0.41x | CHF89.10 Million | CHF36.20 Million | ▲ +27.6% |
| 2018 | 0.32x | CHF94.20 Million | CHF30.00 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow